Advances in Cancer Therapeutics

Submission Deadline: 31 December 2023 (closed)

Guest Editors

Summary

Cancer is the leading cause of worldwide mortalities. Its treatment has always remained challenging due to its complicated aetiology, underlying mechanisms, several pathways controlling the same disease causing gene, complex genetics and influence of environmental factors. Although a great advancement in medicine has led to better management of cancer, improved diagnostics and therapies, still a lot needs to be done in this regard. Prevalence and deaths have been on an increasing verge despite all the collective efforts. Latest technologies such as gene therapy, extracellular vesicles, nanotechnology has revolutionized the cancer treatment.

In this issue we will publish studies related to all kind of therapeutic strategies to understand where are we standing now! Original articles, experimental studies, clinical studies, review articles, opinion articles are welcome.

Articles in these areas or related to therapies are encouraged.

-Targeting Cancer metabolism for cancer therapy

-Targeting the proliferative markers such as Ki67 as cancer therapy

-Mammalian target of Rapamycin (mTOR) as a potential therapeutic strategy

-Novel Peptide biomarkers in cancer diagnostics and therapy

-Natural products in cancer therapy

-Extacellular vesicles/exosomes as diagnostic and therapeutic tool in cancer

-Bacteria mediated cancer therapy

-Prodrugs in cancer therapy

-drug repurposing in cancer therapy

-Nanotechnology in cancer therapy

-Gene editing/ CRISPR-Cas9 in cancer therapy

Keywords

Published Papers